These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20542731)
1. At a crossroads in oncology. Kamb A Curr Opin Pharmacol; 2010 Aug; 10(4):356-61. PubMed ID: 20542731 [TBL] [Abstract][Full Text] [Related]
2. Targeting the unmet medical need: the Abbott Laboratories oncology approach. Carlson DM; Steinberg JL; Gordon G Clin Adv Hematol Oncol; 2005 Sep; 3(9):703-10. PubMed ID: 16224444 [TBL] [Abstract][Full Text] [Related]
3. Is there a case for selectively promiscuous anticancer drugs? Fernández A; Crespo A; Tiwari A Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361 [TBL] [Abstract][Full Text] [Related]
4. Discovery of new anti-cancer agents. Lobbezoo MW; Krul MR; Pinedo HM Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846 [TBL] [Abstract][Full Text] [Related]
5. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Martarelli D; Pompei P; Baldi C; Mazzoni G Cancer Chemother Pharmacol; 2008 Apr; 61(5):809-17. PubMed ID: 17581752 [TBL] [Abstract][Full Text] [Related]
10. Translational research in oncology: key bottlenecks and new paradigms. Simon R Expert Rev Mol Med; 2010 Oct; 12():e32. PubMed ID: 20929594 [TBL] [Abstract][Full Text] [Related]
11. [Molecular therapy targets in lung cancer]. Le Guen Y; Sabatier L; Le Chevalier T; Soria JC Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425 [TBL] [Abstract][Full Text] [Related]
12. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research. Strissel PL; Strick R Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500 [No Abstract] [Full Text] [Related]
13. Novel apoptosis inducing agents in cancer therapy. Mita M; Tolcher AW Curr Probl Cancer; 2005; 29(1):8-32. PubMed ID: 15672328 [No Abstract] [Full Text] [Related]
14. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors. Seliger B; Massa C; Rini B; Ko J; Finke J Trends Mol Med; 2010 Apr; 16(4):184-92. PubMed ID: 20304705 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches. Dumont F; Altmeyer A; Bischoff P Expert Opin Ther Pat; 2009 Jun; 19(6):775-99. PubMed ID: 19456277 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer. Schultze A; Fiedler W Expert Opin Investig Drugs; 2010 Jun; 19(6):777-88. PubMed ID: 20465362 [TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer and targeted therapies. Blackhall FH; Shepherd FA Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981 [TBL] [Abstract][Full Text] [Related]